Scarica l'app Stockscreener
1.7295
3.92%
-0.0705
Precedente Chiudi:
$1.80
Aprire:
$1.8
Volume 24 ore:
7,053
Relative Volume:
0.19
Capitalizzazione di mercato:
$39.43M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-2.84%
1M Prestazione:
+1.74%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$1.7295
$1.803
Intervallo di 1 settimana:
$1.529
$1.82
Portata 52W:
$1.35
$3.50
Rein Therapeutics Inc Stock (RNTX) Company Profile
Nome
Rein Therapeutics Inc
Settore
Industria
Telefono
(737) 802-1989
Indirizzo
12407 N. MOPAC EXPY., AUSTIN
Confronta RNTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RNTX
Rein Therapeutics Inc
|
1.7295 | 39.43M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.03 | 129.44B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.52 | 61.42B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
615.11 | 38.44B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.81 | 33.29B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
241.75 | 26.95B | 3.81B | -644.79M | -669.77M | -6.24 |
Rein Therapeutics Inc Stock (RNTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2017-07-24 | Iniziato | BofA/Merrill | Buy |
| 2017-07-24 | Iniziato | Jefferies | Buy |
| 2017-07-24 | Iniziato | William Blair | Outperform |
Rein Therapeutics Inc Borsa (RNTX) Ultime notizie
Rein Therapeutics to integrate Qureight’s platform in trial of IPF treatment - Yahoo Finance
Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF - PR Newswire
Rein Therapeutics to Present at The Citizens Life Sciences Conference 2025 - Citizen Tribune
Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference - The Victoria Advocate
Breakthrough Lung Regeneration Study: Rein Therapeutics to Present New IPF Treatment Data at ATS 2025 - Stock Titan
Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder LTI-03 for the Treatment of Respiratory Diseases - The Malaysian Reserve
Rein Therapeutics (RNTX) Secures Two Key Patents for Innovative Lung Treatment | RNTX Stock News - GuruFocus
Rein Therapeutics Granted Two Patents Covering The Novel Formulation And Administration Methods Of Dry Powder LTI-03 For Treatment Of Respiratory Diseases - marketscreener.com
Antibiotics Might Increase Risk of Childhood Asthma, Allergies - WFMZ.com
Muscle Quality Could Be Key To Successful Hip Replacement - WFMZ.com
Early Menopause Might Mean Greater Age-Related Brain Decline - WFMZ.com
Microplastics Could Be Contributing To Clogged Arteries - WFMZ.com
Psilocybin Use Dramatically Increasing In U.S. - WFMZ.com
Tesla Board Gets an Earful From State Treasurers Over Musk’s Focus - Yahoo Finance
Rein Therapeutics Announces a Publication in Biomedicines on the - GuruFocus
Rein Therapeutics Announces a Publication in Biomedicines on the Immunomodulatory and Anti-fibrotic Properties of a Caveolin-1-Related Peptide in IPF and PASC-F - MarketScreener
Rein Therapeutics (RNTX) Showcases Promising Peptide for Lung Fi - GuruFocus
Cancer-fighting implant shows promise in treating tumors - WFMZ.com
ITC Makes Affirmative Preliminary Determination in Trade Cases on Chassis from Mexico, Thailand, and Vietnam, Wiley Rein LLP Reports - Yahoo Finance
Equities Analysts Offer Predictions for RNTX Q1 Earnings - Defense World
Rein Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Malaysian Reserve
Will the tariffs lead to a recession? Here's how to know if we're in one - WFMZ.com
Rein Therapeutics, Inc. SEC 10-K Report - TradingView
Health Secretary Says Some Cuts to CDC Will Be Reversed - WFMZ.com
RFK Jr. Touts Vaccine While At Funeral of Texas Girl Who Died of Measles - WFMZ.com
Lawmakers may test Trump on tariffs this week as fears of a GOP election 'decimation' grow - Yahoo Finance
Some Folks Hit With Fees for Using Health Care Message Portals - WFMZ.com
RNTX stock touches 52-week low at $1.6 amid market challenges - Investing.com Canada
RNTX stock touches 52-week low at $1.6 amid market challenges By Investing.com - Investing.com South Africa
Trump says things are 'going very well' after worst stock market drop in years over tariffs - WFMZ.com
Aileron Therapeutics, Inc. Announces New Appointments - MarketScreener
Rein Therapeutics Delays Annual Report Filing - TipRanks
A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial - Frontiers
NCLA Asks Sixth Circuit to Rein in FINRA’s Unlawful Prosecution Regime - Yahoo Finance
Modi Banks on Households to Rein In a $346 Billion Debt Pile - Yahoo Finance
Crude oil drives higher with focus on geopolitical risks, OPEC+ plan to rein in production - Seeking Alpha
Oil prices rise for second consecutive week on expected tighter supply - Yahoo Finance
Congo Considers Asking Indonesia to Help Rein In Cobalt Supply - Yahoo Finance
USAID reinstates contracts for Georgia company that helps feed malnourished kids after Elon Musk responds to CNN reporting - AOL
Reeves Pledges to Rein In UK Borrowing as Welfare Backlash Grows - Yahoo Finance
Daybreak West March 11: Ag chair seeks to rein in CARB costs - Agri-Pulse
OpinionThrough ‘radical transparency,’ Kennedy can finally rein in Big Pharma - AOL
Trump's Plan To Rein In Regulators Could Erode Market Trust, Says $2.3 Trillion Asset Manager - Yahoo Finance
Saratoga Springs event celebrates Belmont countdown while supporting therapeutic horses - WRGB
Carney Vows to Rein In Government Spending, Cap Public Service in Canada - Yahoo Finance
British biotech rebrands as Octavian, seeking to establish new empire after setbacks in 2024 - Fierce Pharma
Should You Invest in Wolfspeed Inc (WOLF) Now? - The News Heater
Esco Technologies, Inc (ESE) Shares Up Despite Recent Market Volatility - The News Heater
PDD Holdings Inc ADR (PDD) Shares Rise Despite Market Challenges - The News Heater
Palantir Technologies Inc (PLTR) Stock: A Closer Look at the Analyst Ratings - The News Heater
Rein Therapeutics (RNTX) Income Statement & Balance Sheet 2025 - MarketBeat
Rein Therapeutics Inc Azioni (RNTX) Dati Finanziari
Non sono disponibili dati finanziari per Rein Therapeutics Inc (RNTX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
5.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):